A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: A. Lasagna, F. Agustoni, E. Percivalle, S. Borgetto, A. Paulet, G. Comolli, A. Sarasini, F. Bergami, J. C. Sammartino, A. Ferrari, F. Zavaglio, F. Arena, D. Lilleri, S. Secondino, M. Falzoni, R. Schiavo, C. Klersy, G. Lo Cascio, L. Cavanna, F. Baldanti, P. Pedrazzoli, I. Cassaniti

Journal title: ESMO Open

Journal number: Volume 6, Issue 5

Journal publisher: Oxford University Press

Published year: 2021

Published pages: 100272

DOI identifier: 10.1016/j.esmoop.2021.100272

ISSN: 0923-7534